Twitxy Saved

An Tran-Duy

@antranduy1

Associate Professor at @HEU_unimelb @UniMelbMDHS | Health Economics Lead at @MischHub | Interested in simulation modelling
Melbourne, Australia findanexpert.unimelb.edu.au/profile/792204… Joined December 2017
146 Following 249 Followers 92 Posts

Latest posts 5

An Tran-Duy @antranduy1
Great to be part of this project. Looking forward to working with fantastic colleagues.
@HEU_unimelb @MischHub
We have been awarded $1,725,343 from MRFF to perform a multicentre RCT comparing the Cross bracing protocol with ACL reconstruction for acute ACL rupture with CI's @KimBennell @ProfDavidHunter @DrIanHarris @agculvenor @HinmanRana Prof Nadine Foster @antranduy1 @AnurikaDeSilva
View quoted post on X
0 replies 0 reposts 10 likes 314 views View on X
An Tran-Duy @antranduy1
Nice to see our work is out.
Not nice to see too little evidence on preference-weighted health-related quality of life in patients with bone sarcoma.
Health utility measures are needed to support economic evaluation in this disease.
Patrick Abraham @PatrickAbraha15 Dec 11, 2023
link.springer.com/article/10.100…

New systematic review from Liam, @antranduy1 @nancydevlin1 and myself.
Good to get this one out the 🚪
@HEU_unimelb @unimelbMSPGH
View quoted post on X
An Tran-Duy @antranduy1
Happy to share this new publication.
The addition of vancomycin to cefazolin prophylaxis was not superior to placebo for the prevention of surgical site infections in arthroplasty among patients without known methicillin-resistant Staphylococcus aureus colonization.
NEJM Verified account @NEJM Oct 18, 2023
In this double-blind, randomized trial, vancomycin was added to cefazolin as surgical prophylaxis for arthroplasty. Surgical-site infections occurred in 4.5% of vancomycin recipients and 3.5% of placebo recipients. Full results of the ASAP trial: nej.md/3S4XNVU
View quoted post on X